NCT00113919 2017-10-16UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma PatientsUniversity of ArkansasPhase 1/2 Terminated14 enrolled 5 charts
NCT00245037 2017-09-27Bu Flu TBIOHSU Knight Cancer InstitutePhase 1/2 Completed147 enrolled 19 charts
NCT00448357 2017-07-17LCCC0510UNC Lineberger Comprehensive Cancer CenterPhase 1/2 Completed54 enrolled 17 charts
NCT00506857 2012-02-28Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell SupportM.D. Anderson Cancer CenterPhase 1/2 Completed82 enrolled 6 charts